Tetra Pak has reported net sales of Euro 11.1 billion for the year 2013 – up 3.5% from 2012.“The combination of strong competition and soft economies in many markets around the globe created a tough
Ingredion has announced appointment of Jorgen Kokke to the role of Vice President and General Manager, Asia-Pacific, at the Ingredion group of companies. Kokke was previously working as Vice President and General Manager for Europe,
Royal DSM, a global life sciences and materials sciences company, is in discussion with China-based vitamin C producer “Aland Nutraceutical Holding Ltd” for the acquisition of the latter. According to the company’s statement DSM is
Sami Labs, Bangalore and Arya Vaidya Sala (AVS), Kottakal have signed a Memorandum of Understanding (MOU) for co-operation in product development and marketing. The MOU was signed at Kottakal by senior authorities of AVS and
Growing at a compound annual growth rate (CAGR) of 17.1%, Indian nutraceuticals market is expected to reach $4 billion by 2018, a new analysis by Frost & Sullivan says.According to the analysis, the penetration of
Phenomenex Inc., a global player in the research and manufacture of advanced technologies for the separation sciences, announced launch of new Kinetex Core-Shell Biphenyl HPLC/UHPLC columns, giving researchers the ideal orthogonal selectivity to traditional C18
Bühler Group, a global player in the field of process engineering, in particular production technologies and services for making foods and advanced materials has acquired an 80% stake in Yaoxian Machinery Guangzhou, a Chinese company
Marico Limited, one of India’s leading Consumer Products Group, announced that Milind Sarwate, Group CFO, Marico Group has resigned from the company to move on to pursue opportunities outside the Group. Joined in 1998 as
The Board of Directors of Marico, one of India’s leading consumer products companies in the global beauty and wellness space has approved the appointment of Saugata Gupta, CEO, Marico as Managing Director and CEO. Saugata
Sun Pharmaceutical Industries is all set to buy Ranbaxy Laboratories for $3.2 billion all-share deal thus creating the fifth-largest generic drug maker. Both the firms are struggling with quality issues in the United States market.Ranbaxy